Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

10.99
Delayed Data
As of Sep 30
 +0.15 / +1.38%
Today’s Change
6.71
Today|||52-Week Range
14.15
+4.27%
Year-to-Date
The Highest-Yielding Drug Stocks
Sep 29 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close10.84
Today’s open10.93
Day’s range10.77 - 11.16
Volume450,668
Average volume (3 months)651,842
Market cap$1.2B
Dividend yield9.10%
Data as of 4:00pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)+89.33%
Earnings growth (this year)+491.25%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+247.57%
P/E ratio64.6
Price/Sales17.94
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SUPNSupernus Pharmaceuti...+0.10+0.41%
DERMDermira Inc+1.15+3.52%
CEMPCempra Inc+0.32+1.34%
PCRXPacira Pharmaceutica...+0.20+0.59%
Data as of 4:00pm ET, 09/30/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)$0.19
Annual revenue (last year)$67.8M
Annual profit (last year)-$18.8M
Net profit margin-27.68%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts

Search for Jobs